Patient C024, Male, 62 years old. Complex medical management visit.
Height: 5'9" (175 cm), Weight: 210 lbs (95 kg), BMI: 31.0 kg/m². High school graduate, retired factory worker.
Confirmed Type 2 Diabetes Mellitus since April 2018 (6+ years duration). Currently on Metformin 1000mg BID, Glipizide 10mg BID.
Poor adherence to medications and lifestyle modifications - admits to missing doses "several times per week" and poor dietary compliance.
Recent HbA1c (February 2024) shows 8.3%, well above target range. Previous values: Nov 2023: 8.1%, Aug 2023: 8.5%.
Active smoker, 2 packs daily (40 cigarettes) for 40+ years (80+ pack-years). Started smoking at age 22 in military.
Smoking cessation history: 5 failed quit attempts over past 20 years. Longest quit period was 2 months in 2015.
Motivation to quit: 3/10 - acknowledges health risks but feels "set in ways" and uses smoking for stress relief.
Occupational history: 35 years in automotive manufacturing with exposure to metal dust, solvents, and industrial chemicals.
Family history: Father died of heart attack at 55 (heavy smoker), mother had diabetes. Brother has lung cancer currently.
Social support: Married but spouse also smokes. Limited family support for cessation. Few non-smoking friends.
Recent spirometry (Jan 2024): FEV1 58% predicted, consistent with moderate airflow limitation.
No cardiac complications documented. Recent stress test (Dec 2023) negative for ischemia. EKG shows normal sinus rhythm.
No history of Congestive Heart Failure or cardiac dysfunction. Echocardiogram (2023) shows EF 60%.
Current medications: Metformin 1000mg BID, Glipizide 10mg BID, Lisinopril 15mg daily, Atorvastatin 40mg daily (4 medications, complexity score: 6).
Recent life stressors: Retirement adjustment difficulties, financial concerns about healthcare costs.
Intensive smoking cessation counseling provided. Referred to tobacco cessation program and pulmonary rehabilitation.
Creatinine 1.2 mg/dL (eGFR 58 mL/min/1.73m²). No recent respiratory infections or exacerbations documented.
